LT
Lynn A. Tetrault
Director

Lynn A. Tetrault insider trades: Rhythm Pharmaceuticals (RYTM) stock buys and sales

Director, Rhythm Pharmaceuticals Last trade Jun 22, 2026 43 Form 4 filings
$3.8M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2015
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Lynn reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 22, 2026RYTM↓ Sell$3.7M
Jun 15, 2026NEO↓ Sell$59K
Jun 9, 2026NEO↓ Sell$60K
May 9, 2025NEO↑ Buy$57K
Sep 10, 2024RYTM↓ Sell$1.0M
Aug 26, 2024RYTM↓ Sell$215K
Aug 12, 2024RYTM↓ Sell$446K
Mar 4, 2024NEO↓ Sell$98K
Nov 19, 2018NEO↓ Sell$208K
Nov 14, 2018NEO↓ Sell$81K
Dec 21, 2015NEO↑ Buy$78K
Dec 7, 2015NEO↑ Buy$27K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RYTM insiders

Open-market trades in the last 12 months

About Lynn A. Tetrault's insider trades

Lynn A. Tetrault is a director at Rhythm Pharmaceuticals (RYTM). Since Dec 7, 2015, Lynn has reported 3 open-market purchases worth $162K and 9 sales worth $5.9M on SEC Form 4. In the last 12 months: 3 sales ($3.8M).

Their filings also include grants and awards (24 filings), option exercises (14 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RYTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.